Our White Paper is Now Available!

Explore how Bright-Dtech enables faster, brighter, and more sensitive biomarker detection.

➡️ Read / Download




Our ultra-fluorescent Bright-Dtech™ lanthanide nanoparticles and immunoassay solutions provide innovative options for biomarker detection in Research and Life Sciences.

Bright-Dtech™ nanoparticles based on patented lanthanide technology
Available conjugated to IgG antibodies, streptavidin, or biotin


We offer our technical expertise to support your R&D projects in biomarker detection through TR-FRET, TR-FLISA, lateral flow applications, and custom antibody conjugation with Bright-Dtech™.


Poly-Dtech is a French company based in Strasbourg, specializing in the R&D of advanced fluorescent nanoparticles and immunoassays for life sciences. We leverage nanoparticle technology to enhance biomarker detection and scientific discovery.

Our patented ultra-bright nanoparticle technology delivers high sensitivity and precision in biomarker detection. Beyond high performance, it can significantly reduce time assay and costs. These nanoparticles offer a powerful alternative to conventional detection methods, with user-friendly “Mix & Read” protocols for applications ranging from basic research to complex assays.

Poly-Dtech aims to accelerate research, drug discovery, and diagnostics with high-performance, cost-effective, and time-saving fluorescence technology. By streamlining R&D, we help laboratories develop faster and more affordable solutions, advancing scientific innovation and supporting earlier detection and more effective treatments.


Stay updated on our recent developments, upcoming events, achievements, product launches, and much more.

Poly-Dtech and Molecular Devices co-developed a new application note demonstrating how advanced fluorescence detection can overcome the traditional limitations of lateral flow assays (LFIA) and enable clinical-grade quantitative biomarker analysis.

The experimental data were generated by Poly-Dtech using prostate-specific antigen (PSA) as a clinically relevant biomarker case study.

This work shows how Bright-Dtech™ lanthanide nanoparticles for LFIA, combined with ScanLater® detection integrated into the iD5 SpectraMax Microplate Reader (Molecular Devices), enable high-precision quantitative biomarker measurements — even in patient plasma samples.

This application note illustrates a concrete step toward bridging point-of-care testing with central lab-level analytical performance.

Poly-Dtech and Molecular Devices co-developed a new application note showing how advanced fluorescence can push the limits of lateral flow assays (LFIA) and turn rapid tests into truly quantitative assays.

The scientific results were generated by Poly-Dtech in collaboration with Universitat Politècnica de València (UPV), using a robust LDH quantitative detection case study.

This application note demonstrates how Bright-Dtech™ lanthanide nanoparticles for LFIA, combined with ScanLater® detection on the iD5 SpectraMax Microplate Reader (Molecular Devices), enable ultra-sensitive and quantitative lateral flow testing.

This work illustrates the strong synergy between nanotechnology, LFIA-dedicated reagents and advanced detection instrumentation

As we step into 2026, the Poly-Dtech team wishes you a very happy New Year.

We sincerely thank our partners, clients and collaborators for their trust and continued support.

This new year will bring exciting scientific challenges, new developments, and continued innovation in advanced fluorescent nanomaterials for drug discovery and research.

We look forward to building the future together.


Applications

Applications

TR-FRET
TR-FLISA (ELISA)
Lateral Flow
Cell Imaging

previous arrow
next arrow